Atrial Fibrillation Clinical Trials in Nanjing
3 recruitingNanjing, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
PulseSelect™ PFA Global Registry
Atrial Fibrillation
Medtronic Cardiac Ablation Solutions1,950 enrolled28 locationsNCT06393920
Recruiting
Not Applicable
Catheter Ablation in Atrial Fibrillation Patients With HFpEF (STABLE-SR IV Trial)
Atrial FibrillationHFpEF - Heart Failure With Preserved Ejection Fraction
The First Affiliated Hospital with Nanjing Medical University436 enrolled1 locationNCT06125925